This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Doxycycline hyclate

Read time: 1 mins
Marketing start date: 14 Jul 2024

Summary of product characteristics


Effective Time

20221105

Version

5

Spl Product Data Elements

Doxycycline hyclate Doxycycline hyclate DOXYCYCLINE HYCLATE DOXYCYCLINE ANHYDROUS ALCOHOL AMMONIA ANHYDROUS LACTOSE BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM D&C RED NO. 28 FD&C BLUE NO. 1 FERROSOFERRIC OXIDE GELATIN ISOPROPYL ALCOHOL MAGNESIUM STEARATE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE TITANIUM DIOXIDE BLUE WHITE CAPSULE CHL;D75 Doxycycline hyclate Doxycycline hyclate DOXYCYCLINE HYCLATE DOXYCYCLINE ANHYDROUS ALCOHOL AMMONIA ANHYDROUS LACTOSE BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM D&C RED NO. 28 FD&C BLUE NO. 1 FERROSOFERRIC OXIDE GELATIN ISOPROPYL ALCOHOL MAGNESIUM STEARATE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE TITANIUM DIOXIDE LIGHT BLUE LIGHT BLUE CAPSULE CHL;D76

Application Number

ANDA207774

Brand Name

Doxycycline hyclate

Generic Name

Doxycycline hyclate

Product Ndc

70771-1359

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1358-7 Doxycycline hyclate capsules, 50 mg Rx only 50 capsules NDC 70771-1359-7 Doxycycline hyclate capsules, 100 mg Rx only 50 capsules Doxycycline hyclate capsules Doxycycline hyclate capsules

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.